Combination Therapy Stroke Trial: Recombinant Tissue-Type Plasminogen Activator with/without Lubeluzole

Publisher： Karger

E-ISSN： 1421-9786|12|3|258-263

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.12, Iss.3, 2001-10, pp. : 258-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Centenarian Stroke Treated with Tissue-Type Plasminogen Activator

By  

Cerebrovascular Diseases, Vol. 13, Iss. 4, 2002-05 ,pp. : 285-287

Karger

Access to resources Recommend Favorite

Repeated Intravenous Treatment with Recombinant Tissue-Type Plasminogen Activator in Patients with Acute Ischemic Stroke

By  

European Neurology, Vol. 74, Iss. 3-4, 2015-09 ,pp. : 127-134

Karger

Access to resources Recommend Favorite

AMYLOID PEPTIDES STIMULATE TISSUE-TYPE PLASMINOGEN ACTIVATOR BUT NOT RECOMBINANT PROUROKINASE

By Wnendt S.   Wetzels I.   Gunzler W.A.  

Thrombosis Research, Vol. 85, Iss. 3, 1997-02 ,pp. : 217-224

Elsevier

Access to resources Recommend Favorite

4G/5G Polymorphism of the Plasminogen Activator Inhibitor-1 Gene and Insertion/Deletion Polymorphism of the Tissue-Type Plasminogen Activator Gene in Atherothrombotic Stroke

By  

Cerebrovascular Diseases, Vol. 11, Iss. 4, 2001-05 ,pp. : 294-299

Karger

Access to resources Recommend Favorite

Early Neurological Deterioration following Intravenous Recombinant Tissue Plasminogen Activator Therapy in Patients with Acute Lacunar Stroke

By  

Cerebrovascular Diseases, Vol. 26, Iss. 4, 2008-08 ,pp. : 355-359

Karger

Access to resources Recommend Favorite